Evidence map›Paper›PMID 20170421›Full record

ReviewImmunopharmacology and immunotoxicology2010

Translational systems approaches to the biology of inflammation and healing.

Yoram Vodovotz, Gregory Constantine, James Faeder, Qi Mi, Jonathan Rubin, John Bartels, Joydeep Sarkar, Robert H Squires, David O Okonkwo, Jörg Gerlach and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Immunopharmacology and immunotoxicology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Chondroitin Sulfate fromMolecules (Basel, Switzerland) · 2023
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Yoram VodovotzDepartment of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. vodovotz@upmc.edu
Gregory Constantine
James Faeder
Qi Mi
Jonathan Rubin
John Bartels
Joydeep Sarkar
Robert H Squires
David O Okonkwo
Jörg Gerlach
Ruben Zamora
Shirley Luckhart
Bard Ermentrout
Gary An
University of Pittsburgh · USMcGowan Institute for Regenerative Medicine · USNorthwestern University · USUniversity of California Davis Medical Center · US

Funding

Multi-Center Group to Study Acute Liver Failure in ChildU01DK072146 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SQUIRES, ROBERT H · 2005 to 2014
$23.2M
Regulation of Intestinal Mucosal Injury & Repair After Trauma/Hemorrhagic ShockP50GM053789 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VODOVOTZ, YORAM · 1997 to 2013
$18.0M
Systems Engineering of Pheresis Intervention for SepsisR01HL080926 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELLUM, JOHN A · 2005 to 2009
$6.8M
Systems biology approach to MAPK regulation of malaria infection in A. stephensiR01AI080799 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LUCKHART, SHIRLEY, VODOVOTZ, YORAM · 2009 to 2013
$3.4M
Hybrid Model of Vocal Inflammation and Tissue MobilizationR01DC008290 · NIDCD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VERDOLINI, KATHERINE · 2007 to 2011
$2.8M
Metabolic-Inflammatory Systems in Irreversible ShockR01HL076157 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PUYANA, JUAN CARLOS · 2004 to 2007
$1.4M
Mathematical Modeling of Inflammation in ARDSR33HL089082 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VODOVOTZ, YORAM · 2008 to 2010
$1.3M
Modeling the acute inflammatory responseR01GM067240 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CLERMONT, GILLES · 2002 to 2005
$1.3M
NHLBI NIH HHS R01 HL076157NHLBI NIH HHS R01 HL080926NHLBI NIH HHS R01-HL080926NHLBI NIH HHS R01-HL-76157NHLBI NIH HHS R33 HL089082NHLBI NIH HHS R33-HL-089082NIAID NIH HHS R01 AI080799NIAID NIH HHS R01-AI080799NIDCD NIH HHS R01 DC008290NIDDK NIH HHS U01 DK072146NIDDK NIH HHS U01-DK072146-05NIGMS NIH HHS P50 GM053789NIGMS NIH HHS P50-GM-53789NIGMS NIH HHS R01 GM067240NIGMS NIH HHS R01-GM-67240
6 · The paper itself

Abstract

Inflammation is a complex, non-linear process central to many of the diseases that affect both developed and emerging nations. A systems-based understanding of inflammation, coupled to translational applications, is therefore necessary for efficient development of drugs and devices, for streamlining analyses at the level of populations, and for the implementation of personalized medicine. We have carried out an iterative and ongoing program of literature analysis, generation of prospective data, data analysis, and computational modeling in various experimental and clinical inflammatory disease settings. These simulations have been used to gain basic insights into the inflammatory response under baseline, gene-knockout, and drug-treated experimental animals for in silico studies associated with the clinical settings of sepsis, trauma, acute liver failure, and wound healing to create patient-specific simulations in polytrauma, traumatic brain injury, and vocal fold inflammation; and to gain insight into host-pathogen interactions in malaria, necrotizing enterocolitis, and sepsis. These simulations have converged with other systems biology approaches (e.g., functional genomics) to aid in the design of new drugs or devices geared towards modulating inflammation. Since they include both circulating and tissue-level inflammatory mediators, these simulations transcend typical cytokine networks by associating inflammatory processes with tissue/organ impacts via tissue damage/dysfunction. This framework has now allowed us to suggest how to modulate acute inflammation in a rational, individually optimized fashion. This plethora of computational and intertwined experimental/engineering approaches is the cornerstone of Translational Systems Biology approaches for inflammatory diseases.

Indexed as

Models, BiologicalSystems BiologyAnimalsClinical Trials as TopicCytokinesDisease Models, AnimalHumansInflammationWound HealingCytokines

Identifiers

PMID20170421
PMCPMC3134151
OpenAlexW2143719559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.